Glue-sniffing neuropathy.

PubWeight™: 1.99‹?› | Rank: Top 2%

🔗 View Article (PMID 1119959)

Published in Arch Neurol on March 01, 1975

Authors

R Korobkin, A K Asbury, A J Sumner, S L Nielsen

Articles citing this

Investigation of peripheral neuropathy. J Neurol Neurosurg Psychiatry (1995) 1.94

Toxic polyneuropathy of shoe-industry workers. A study of 122 cases. J Neurol Neurosurg Psychiatry (1976) 1.24

Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J Neurol Neurosurg Psychiatry (1975) 1.21

Neurotoxic effects of n-hexane on the human central nervous system: evoked potential abnormalities in n-hexane polyneuropathy. J Neurol Neurosurg Psychiatry (1987) 1.20

Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing. J Neurol Neurosurg Psychiatry (1983) 1.20

Possibilities of detecting health effects by studies of populations exposed to chemicals from waste disposal sites. Environ Health Perspect (1985) 1.17

Giant axonal neuropathy. Involvement of peripheral nerve, myenteric plexus and extra-neuronal area. Acta Neuropathol (1977) 1.02

Infantile chronic peripheral neuropathy with giant axons. Report of a case. Acta Neuropathol (1977) 0.95

Patients with n-hexane induced polyneuropathy: a clinical follow up. Br J Ind Med (1990) 0.91

N-hexane neuropathy in offset printers. J Neurol Neurosurg Psychiatry (1993) 0.88

Pathology of skeletal muscle and intramuscular nerves in infantile neuroaxonal dystrophy. Acta Neuropathol (1986) 0.85

An electrophysiological follow up of patients with n-hexane polyneuropathy. Br J Ind Med (1991) 0.84

Giant axonal neuropathy: acceleration of neurofilament transport in optic axons. Proc Natl Acad Sci U S A (1985) 0.83

Clinical expression of neurotoxic injury and diagnostic use of electromyography. Environ Health Perspect (1978) 0.81

Glue-sniffing neuropathies. Can Fam Physician (1993) 0.79

Solvent misuse. Br Med J (Clin Res Ed) (1985) 0.77

Persistent visual hallucinations secondary to chronic solvent encephalopathy: case report and review of the literature. J Neurol Neurosurg Psychiatry (1983) 0.77

Environmental effects on the central nervous system. Environ Health Perspect (1977) 0.76

Peripheral neuropathy following intentional inhalation of naphtha fumes. Can Med Assoc J (1984) 0.76

Occupational peripheral neuropathies. West J Med (1982) 0.75

Environmental chemicals and nervous system dysfunction. Yale J Biol Med (1979) 0.75

Progressive optic neuropathy and sensorineuronal hearing loss due to chronic glue sniffing. J Neurol Neurosurg Psychiatry (1983) 0.75

Reversible cerebral and brain stem dysfunction in n: Hexane neuropathy. Ann Indian Acad Neurol (2015) 0.75

Giant axonal neuropathy: possibly secondary to vitamin b12 malabsorption. Acta Neuropathol (1977) 0.75

Neurotoxic properties of certain aliphatic hexacarbons. Proc R Soc Med (1977) 0.75

Spastic paraplegia with neurogenic amyotrophy manifesting ballooned axons in sural nerve. Acta Neuropathol (1977) 0.75

Articles by these authors

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology (2005) 3.67

Locally induced digital vasospasm detected by delayed rewarming in Raynaud's phenomenon of occupational origin. Br J Ind Med (1981) 3.20

Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61

Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol (1981) 2.53

Raynaud phenomena and finger systolic pressure during cooling. Scand J Clin Lab Invest (1978) 2.49

Measurement of digital blood pressure after local cooling. J Appl Physiol Respir Environ Exerc Physiol (1977) 2.41

Reasons for staying alive when you are thinking of killing yourself: the reasons for living inventory. J Consult Clin Psychol (1983) 2.38

Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32

Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med (1979) 2.21

Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther (2012) 2.20

Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology (2008) 2.19

Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology (2008) 2.15

The role of Schwann cells in the formation of "onion bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol (1967) 2.13

Children and nocturnal snoring: evaluation of the effects of sleep related respiratory resistive load and daytime functioning. Eur J Pediatr (1982) 2.04

Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain (1970) 1.96

Wasting of the hand associated with a cervical rib or band. J Neurol Neurosurg Psychiatry (1970) 1.93

Giant axonal neuropathy--a unique case with segmental neurofilamentous masses. Acta Neuropathol (1972) 1.91

Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85

Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol (1977) 1.84

HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81

Subacute encephalitis in acquired immune deficiency syndrome: a postmortem study. Am J Clin Pathol (1984) 1.79

Painful diabetic neuropathy. A morphometric study. Arch Neurol (1976) 1.77

Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc (1969) 1.74

Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nat Genet (1999) 1.74

Encephalopathy and peripheral neuropathy following diethylene glycol ingestion. Neurology (2005) 1.73

Multifocal demyelinating neuropathy with persistent conduction block. Neurology (1982) 1.69

A review of 50 children with obstructive sleep apnea syndrome. Lung (1981) 1.64

The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology (1982) 1.63

Blood pressure measurement of all five fingers by strain gauge plethysmography. Scand J Clin Lab Invest (1976) 1.61

Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59

Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve (2000) 1.57

Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain (1975) 1.56

Closure of digital arteries in high vascular tone states as demonstrated by measurement of systolic blood pressure in the fingers. Scand J Clin Lab Invest (1977) 1.54

Giant axonal neuropathy. Pediatrics (1972) 1.53

Influence of anterior mitral leaflet second-order chordae on leaflet dynamics and valve competence. Ann Thorac Surg (2001) 1.52

Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol (1996) 1.51

Cold response of digital arteries in chain saw operators. Br J Ind Med (1982) 1.51

Sensory perineuritis. Arch Neurol (1972) 1.51

Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res (1973) 1.51

Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol (1968) 1.50

Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients. Ann Oncol (2002) 1.49

Leukoencephalopathy in patients treated with amphotericin B methyl ester. J Infect Dis (1982) 1.49

Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy. Lancet (1996) 1.47

The acute sensory neuronopathy syndrome: a distinct clinical entity. Ann Neurol (1980) 1.47

Neuralgic amyotrophy: an increasingly diverse entity. Muscle Nerve (1987) 1.47

Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol (1985) 1.46

The effects of providing therapists with feedback on patient progress during psychotherapy: are outcomes enhanced? Psychother Res (2001) 1.46

Diabetic neuropathy. Ann Neurol (1984) 1.44

Idiopathic polyneuritis after surgery. Arch Neurol (1968) 1.43

Physiologic-pathologic correlation in Guillain-Barré syndrome in children. Neurology (2000) 1.43

Focal conduction block in n-hexane polyneuropathy. Muscle Nerve (1998) 1.43

Schwann cell proliferation in developing mouse sciatic nerve. A radioautographic study. J Cell Biol (1967) 1.41

Immediate surgery is the treatment of choice for carpal tunnel syndrome. Muscle Nerve (1995) 1.41

Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40

[The temperature in medical practice]. Ugeskr Laeger (1991) 1.38

Vector short-latency somatosensory-evoked potentials after median nerve stimulation. Muscle Nerve (1990) 1.38

Duration of synthesis phase in neuilemma cells in mouse sciatic nerve during degeneration. Exp Neurol (1970) 1.34

Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34

Cervical internal carotid artery dissecting hemorrhage: diagnosis using MR. Radiology (1986) 1.32

Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries. Arch Neurol (1974) 1.31

Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med (1968) 1.30

Congenital central alveolar hypoventilation syndrome in six infants. Pediatrics (1982) 1.29

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol (1999) 1.28

Prevalence of primary Raynaud phenomena in young females. Scand J Clin Lab Invest (1978) 1.27

Experimental allergic neuritis induced by sensitization with galactocerebroside. Science (1979) 1.26

Adipose tissue blood flow and insulin disappearance from subcutaneous tissue. Clin Pharmacol Ther (1979) 1.26

Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum. Lab Invest (1978) 1.25

In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta (1999) 1.24

Hereditary sensory neuropathy. A clinical and ultrastructural study. J Neurol Sci (1970) 1.22

Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis. Muscle Nerve (2000) 1.20

The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia (1976) 1.20

Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J Neurosurg (1971) 1.20

Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19

A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Ann Neurol (1990) 1.17

Distal neuropathy in experimental diabetes mellitus. Ann Neurol (1980) 1.15

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology (1998) 1.14

'Near-miss' for sudden infant death syndrome infants: a clinical problem. Pediatrics (1983) 1.14

Renaut bodies. A forgotten endoneurial structure. J Neuropathol Exp Neurol (1973) 1.14

Pain due to peripheral nerve damage: an hypothesis. Neurology (1984) 1.14

Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain (1994) 1.12

Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PM R (2009) 1.12

Conduction block in rat myelinated fibres following acute exposure to anti-galactocerebroside serum. J Physiol (1982) 1.11

Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10

Postsurgical idiopathic brachial neuritis. Muscle Nerve (1994) 1.10

The physiological basis for symptoms in Guillain-Barré syndrome. Ann Neurol (1981) 1.09

Ultrastructure of a "pineocytoma". J Neuropathol Exp Neurol (1975) 1.09

The role of radiation therapy in the treatment of astrocytomas. Cancer (1975) 1.09

Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09

Mixed and obstructive sleep apnea and near miss for sudden infant death syndrome: 2. Comparison of near miss and normal control infants by age. Pediatrics (1979) 1.09

A syndrome of asymmetric limb weakness with motor conduction block. Neurology (1990) 1.08

The relationship between head circumference and the development of communicating hydrocephalus in infants following intraventricular hemmorrhage. Pediatrics (1975) 1.08